Meeting Pharma’s Need for Ever-Expanding Labels

Mike Miller has seen a steady increase in the required information and font sizes needed for pharmaceutical labeling. “This continued increase requires our clients to expand their packaging and find creative ways to deliver that information,” says Miller, who is vice president of manufacturing and co-founder of Platinum Press Inc. (Grand Prairie, TX;

No votes yet

PPLA Says GAO Report On E-Labeling Supports Argument Against House Bill

A Government Accountability Office (GAO) report bolsters the Pharmaceutical Printed Literature Association’s (PPLA) position against a House bill amendment that would allow making label content available exclusively in electronic form.

Chesapeake Acquired by The Carlyle Group

The Carlyle Group has acquired global paper-based packaging supplier Chesapeake from Irving Place Capital and funds managed by Oaktree Capital Management, it was reported in a statement. Chesapeake manufactures leaflets, labels, and cartons, primarily for the pharmaceutical, confectionery, and premium drinks industries. With headquarters in Nottingham, UK, the company employs nearly 5000 at 38 facilities in nine countries and had revenues of €580m in 2012.

Printed Literature Industry Opposes E-Labeling Provision Tacked On House Bill

The pharmaceutical printed literature industry has mobilized to block a proposed amendment that would allow electronic labeling for literature intended for healthcare professionals.

ISPE Surveying Patients on Clinical Trial Materials

ISPE, the International Society for Pharmaceutical Engineering, reports that it is surveying patients globally on their experiences with clinical trial materials. The goal is to gather feedback on the suitability of clinical trial packaging, label information and design, interacting with clinical trial technologies, and transportation and storage, ISPE reports in a press release. With a target of 2000 or more patients from around the world, this study is the first known of its kind in size and scope, it reports.

Preparing for Printing Changes: USP Ch <1> Labeling Revisions

Taking effect on December 1, 2013, is the United States Pharmacopeia (USP) General Chapter <1> Injections, Labeling on Ferrules and Cap Overseals (USP 34-NF 29 November 1, 2010) revised standard regarding labeling for cap overseals and ferrules on injectable drug vials. The revised chapter covers all injectable drug products, human and veterinary, intended for sale in the United States.

West Pharmaceutical Services Inc.’s Carol Mooney, Global Market Segment Director, Pharma/Biotech, offers guidance on complying with the new standards.

Q. How does the new standard impact pharmaceutical packaging?

No votes yet

Color Coding to Hasten Identification, Reduce Errors

Medline Industries Inc. ( has launched a new system of color coding and labeling in order to ease surgical procedure pack identification. Medline’s EMPOWER Packaging System features color-coded outer packing labels and matching color-coded insert forms.

Procedure packs are typically swathed in common blue surgical wrap, making it difficult for nurses or other practitioners to identify specific packs quickly. And such homogeneity has led to error. According to a recent survey conducted by Medline of more than 400 operating room staff, 67% of respondents said that the incidence of picking the incorrect pack occurs at least several times a year.

No votes yet

Standardizing Labeling

ISPE seeks to improve clinical trial personnel understanding and practitioner patient compliance through standardized booklet labels.

ISPE ( has developed industry guidance to help companies conducting global clinical trials standardize booklet labels. Available for purchase on the group’s Web site (, the ISPE Good Practice Guide: Booklet Labels was developed to help train clinical trial personnel on proper booklet label use.

Your rating: None Average: 3.5 (2 votes)

New OTC Cold Product Packaging Anything but Common

Packaging for Zicam Cold Remedy has been redesigned by Beardwood&Co. The over-the-counter product family marketed and sold by Matrixx Initiatives Inc. includes 15 SKUs, including Rapidmelt tablets, chewables, liquid lozenges, crystals packets, and oral mist.

“We helped define this different segment,” says Julia Beardwood, founder, Beardwood&Co, in a press release. “But, to be successful, we had to help consumers quickly sort through this myriad of products in the cold aisle and understand what Zicam is and when to take it.”

FDA Adds Heart Risk Warning to Pfizer Antibiotic

The agency is adding new warnings to the label of Zithromax, an antibiotic used to treat infections such as bronchitis and pneumonia.

The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.

The agency is adding new warnings to the label of Zithromax, which is commonly used to treat bronchitis, pneumonia and other infections.

Doctors should consider prescribing other antibiotics to patients at risk of heart problems, including those with irregular heartbeats or low levels of potassium or magnesium in their blood.

No votes yet
Syndicate content